MedWatch

Lundbeck counts on employee growth despite economic turmoil

Although the company can feel the impacts of economic uncertainty, CEO Deborah Dunsire wants to hire more people in 2023.

Deborah Dunsire, CEO of Lundbeck | Photo: Gregers Tycho/ERH

Inflation, war, and supply issues have put dealing with economic risks at the top of Lundbeck’s agenda, according to the pharmaceutical firm’s chief executive, Deborah Dunsire.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs